SAAs are used in clinical medicine for the following indications: * Prostate cancer in men * Benign prostatic hyperplasia in men * Androgen-dependent skin and hair conditions like acne, hirsutism, seborrhea, and pattern hair loss (androgenic alopecia) in women * Hyperandrogenism, such as due to polycystic ovary syndrome or congenital adrenal hyperplasia, in women * As a component of hormone therapy for transgender women * Precocious puberty in boys * Hypersexuality and paraphilias in men and sex offenders * Priapism in men Available forms s marketed for clinical or veterinary use Generic name Class Type Brand name(s) Route(s) Launch Status a<unk>  Androgen synthesis inhibitor Zytiga Oral 2011 Available 523,000<unk>  Progestin Gestanin, Perselin Oral 1961 Availableb 61,800<unk>  Progestin; AR antagonist Belara, Prostal Oral 1965 Available 220,000<unk>  Progestin; AR antagonist Androcur, Diane Oral, 1973 Available 461,000<unk>  Progestin; AR antagonist Tardak Veterinary 1972 Veterinary 42,600<unk>  Progestin Depostat, Primostat 1973 Availableb 119,000<unk>  Progestin Delalutin, Proluton 1954 Available 108,000<unk>  Progestin Provera, Depo-Provera Oral, , 1958 Available 1,250,000<unk>  Progestin; AR antagonist Megace Oral 1963 Available 253,000<unk>  Progestin; AR antagonist Ypozane Veterinary 2007 Veterinary 87,600<unk>  Progestin; AR antagonist Prostetin, Roxenone 1981 Availableb 36,100<unk>  AR antagonist Aldactone Oral, topical 1959 Available 3,010,000 Footnotes: a = Hits = Google Search hits (as of February 2018). b = Availability limited / mostly discontinued. Class:<unk>  = . Nonsteroidal = . Sources: See individual articles.
Steroidal antiandrogen
Nonsteroidal antiandrogen
Antiandrogen
N-Terminal domain antiandrogen
Selective androgen receptor modulator
Nonsteroidal estrogen
Thyroid blocker
Antiprogestogen